Issue 23 - The Cancer Letter

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

How drugs go viral: Flatiron's real-world data show how uptake happens

Maria Koehler: Real-world data is "truly a revolution"

Francis Collins to stay on as NIH director in Trump administration

Michael Birrer named director of the University of Alabama at Birmingham Comprehensive Cancer Center

Angela Hartley Brodie, pioneer in the development of breast cancer treatment, dies at 82

Aggressive marketing transforms tobacco use into social justice issue, report states

In Brief

Ben Melson rejoins MD Anderson as chief financial officer

Jeffrey Molter named director of communications at NYU Perlmutter Cancer Center

ACCC delivers immunotherapy education in community setting

Andy North & Friends raise $1.05 million for UW Carbone Cancer Center

Funding Opportunities

DOD publishes research opportunities in prostate cancer

Drugs & Targets

BMS, Novartis announce collaboration focused on metastatic colorectal cancer

Roche announces FDA approval of companion diagnostic to identify ALK-positive non-small cell lung cancer patients

FDA Approves Hologic's Genius 3D Mammography Exam

Amgen and Allergan announce FDA advisory committee meeting to review ADP 215, a biosimilar candidate to Bevacizumab

Hitachi and MD Anderson to collaborate in research in oropharyngeal cancer

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login